Could a simple drug cut dangerous blood pressure swings in liver transplants?
NCT ID NCT04901169
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a drug called Angiotensin II can help control blood pressure during liver transplant surgery, reducing the need for other strong blood pressure medicines. It involves 50 adults with severe liver disease who are receiving a liver from a deceased donor. The goal is to see if this approach makes the surgery safer and more stable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells predict herpesvirus danger in transplant patients?
- Can a helping hand ease the burden of pediatric liver transplants?
- Can a helping hand ease the leap to adult transplant care?
- Muscle quality on MRI may foretell liver transplant success
- Better crystal ball for liver crisis: new scores put to the test
- A machine that keeps donor livers alive outside the body — could it transform transplantation?